Ordinarily, I would have agreed but not anymore. The market is done with Oncosil. All of the delays, dramas, etc etc. The market wouldn’t care if Oncosil produced $10 million revenue, $20 million revenue or possibly even $50 million in revenue.
The market has moved on from the Oncosil story. It’s sad but that’s the reality. No point keep telling shareholders to be patient. The market for the 50th time has moved on, to more exciting stories. Oncosil is boring.
OSL Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)